Abstract | A defining characteristic of the immune system is the constant movement of many of its constituent cells through the secondary lymphoid tissues, mainly the spleen and lymph nodes, where crucial interactions that underlie homeostatic regulation, peripheral tolerance and the effective development of adaptive immune responses take place. What has only recently been recognized is the role that non-haematopoietic stromal elements have in many aspects of immune cell migration, activation and survival. In this Review, we summarize our current understanding of lymphoid compartment stromal cells, examine their possible heterogeneity, discuss how these cells contribute to immune homeostasis and the efficient initiation of adaptive immune responses, and highlight how targeting of these elements by some pathogens can influence the host immune response.
The proper functioning of the immune system requires highly dynamic interactions between diverse cell populations that are specialized to protect the body against unwanted invaders. Over the past century, many studies have documented the location and organization of cellular immune constituents in primary and secondary lymphoid tissues. Recently, the use of intravital multi-photon laser scanning microscopy has afforded researchers an inside look into the dynamic events that take place in lymphoid and non-lymphoid tissues 1 . Few studies, however, have examined how these events are influenced by the surrounding tissue environment, in particular the non-haematopoietic stromal cells and other cells that support the parenchyma of the lymphoid organs and peripheral tissues.
In this Review, we discuss our current understanding of the many roles of the stromal cells in secondary lymphoid organs (SLOs) and the specialization of various stromal cell subsets. These cells contribute to the development of immune responses by providing chemokines and cytokines, acting as scaffolds for cell trafficking, presenting antigen and expressing adhesion and inhibitory molecules, leading to either tolerance or active immune responses. The phenotype and location of lymphoid stromal cells and the signals they produce can provide regional control to nurture or direct the most appropriate responses to pathogens. The induction of tertiary lymphoid tissues that contain stromal networks that are strikingly similar to those in SLOs is a further indication of the importance of these networks for immune responses
. We also discuss evidence that several pathogens target lymphoid system stromal cells during infection and consider the implications of such targeting for pathogen persistence and immunosuppression.
Secondary lymphoid organ organization
The SLOs form a network of structurally and functionally heterogeneous tissues that are designed as a filtration and surveillance system to capture pathogens and their antigens and then present the antigens in an appropriate manner to cells of the immune system. Of these tissues, the lymph nodes and spleen have been the most extensively studied, although the structures of Peyer's patches and other types of mucosa-associated lymphoid tissue (MALT) have many important similarities. The complex microarchitecture of SLOs is supported by networks of endothelial and mesenchymal stromal cells 2 .
Structure of the spleen. The spleen is one of the body's main filters of blood and is situated in a prime position to capture antigens and allow cells of both the innate and adaptive immune systems to respond rapidly to blood-borne pathogens. The spleen is surrounded by a fibrous capsule from which trabeculae protrude into the tissue, providing structural support for the organ and its vasculature 3 . Blood vessels enter the spleen at the hilum and branch into central arterioles, which are
Primary and secondary lymphoid tissues
The primary lymphoid organs are the bone marrow and thymus, which are involved in the development of mature B and T cells, respectively. The secondary lymphoid organs, including the spleen, lymph nodes and mucosa-associated lymphoid tissues, assist in the induction of immune responses by capturing and presenting antigens and facilitating interactions between cells of the innate and adaptive immune systems.
Multi-photon laser scanning microscopy
A fluorescence imaging technique that makes use of the fact that fluorescent molecules can absorb two photons nearly simultaneously during excitation before they emit light. This technique uses infrared lasers that reduce heat damage and light scattering and facilitate imaging deeper into tissues, allowing the study of cellular interactions in real time.
surrounded by the organized lymphoid compartments known as white pulp (FIG. 1) . Branches of the central arterioles terminate at marginal zones, which form the interface between the white pulp and the red pulp of the spleen. In mice, the splenic white pulp consists of T cell zones surrounding a central arteriole, as well as associated B cell follicles and the surrounding marginal zone. In the human spleen, the marginal zone is larger and is surrounded by a perifollicular zone that separates the white pulp from the red pulp 4 . Lymphocytes and other immune cells mainly enter the spleen at the marginal zone. Many lymphocytes exit the red pulp through the splenic veins 5 , and the remainder of the cells migrate into the white pulp at regions where the T cell zones meet the marginal zone, which are known as the marginal zone bridging channels 6, 7 . It is less clear where lymphocytes exit the white pulp, although they might do so through a network of efferent lymphatic vessels that form around central arterioles in the white pulp and drain through the trabeculae and the splenic hilus 8 . Activated T cells might exit the white pulp through the marginal zone bridging channels 9 and enter the blood through the sinuses in the red pulp.
The T cell zones in the spleen contain both CD4 + and CD8 + T cells and subsets of dendritic cells (DCs). These cells are supported by a network of stromal cells known as fibroblastic reticular cells (FRCs). In the B cell follicles, B cells are supported by a network of follicular dendritic cells (FDCs) and a more diffuse network of other stromal cells towards the periphery of the follicles (FIG. 1; see Supplementary information S1 (figure)). The stromal cells of the marginal zone, particularly those surrounding the B cell follicles, seem to have several unique features, and as such have been suggested to constitute a new subset of stromal cells known as marginal reticular cells (MRCs) 10 . The surrounding marginal zone contains marginal zone macrophages, marginal zone metallophilic macrophages that express CD169, subsets of DCs and marginal zone B cells, among a dense network of stromal cells. Antigens, particles and pathogens that enter the spleen from the blood are taken up by the marginal zone phagocytes and B cells. Marginal zone B cells and DCs can then migrate into the white pulp, where they deliver or present antigen to B and T cells, respectively 3, 11 .
Structure of the lymph nodes. Lymph nodes are encapsulated lymphoid organs that receive an extracellular fluid filtrate (lymph) through a series of non-haematogenous vessels (lymphatics) that drain the tissues and organs of the body. Immediately beneath the lymph node capsule is the subcapsular sinus (SCS), in which afferent lymphatics empty their content, delivering molecules, antigens, microorganisms and cells such as lymphocytes and antigen-presenting cells (ApCs) from the tissues (FIG. 2) . Macrophages line the SCS and capture antigens and particles that enter the lymph node through the lymph 12 , similarly to the macrophages in the splenic marginal zone. Lymphocytes mainly enter lymph nodes from the blood through specialized high endothelial venules (HeVs) in the lymph node cortex 13 . HeVs are often arranged in regions between the B and T cell zones known as cortical ridges 14 . As in the spleen, the T cell zones of lymph nodes contain CD4 + and CD8 + T cells and subsets of DCs anchored to a network of FRCs and reticular fibres. Similarly, the B cell follicles contain networks of FDCs and a more peripheral network of stromal cells that border the T cell zones and the SCS. Similar to the spleen, the stromal cells found between B cell follicles and the SCS in the lymph nodes have unique properties that distinguish them as MRCs 10 . Vascular endothelial cells and lymphatic endothelial cells are other non-haematopoietic cells that are also abundant in SLOs. In lymph nodes, the specialized vascular endothelial cells in HeVs have a distinct morphology 15 and express molecules that are crucial for lymphocyte entry into the lymph node, such as peripheral node addressin (pNAD; also known as CD62L ligand) and CC-chemokine ligand 21 (CCL21). Lymphatic endothelial cells express the CD44 homologue lymphatic vessel endothelial hyaluronan receptor 1 (LYVe1), as well as various adhesion molecules and CCL21, which are involved in cell entry into the lymphatics 16 . Lymphocyte entry into the cortical and medullary lymphatic sinuses also requires sphingosine 1-phosphate receptor 1 (S1p 1 ) and its ligand, S1p 17 , which is produced and secreted in the lymph by nonhaematopoietic cells, possibly lymphatic endothelial cells 18 . Additional studies are required to determine whether the control of lymphocyte entry into lymphatics by S1p 1 occurs solely through T cell-intrinsic signalling 19 or whether signalling in endothelial cells controls a stromal barrier 20 , or both.
Box 1 | Stromal elements of tertiary lymphoid tissues
Tertiary lymphoid tissues (TLTs) can form at sites of inflammation in organs and peripheral tissues. They are induced by acute inflammation, for example in the lungs after respiratory influenza virus infection 124 . Other viral and bacterial infections also induce TLTs in mice and humans (reviewed in reF. 125) . Chronic inflammatory states, such as those accompanying autoimmune reactions (including rheumatoid arthritis, type 1 diabetes and multiple sclerosis), also induce TLT formation 125 . The pathways that drive TLT formation remain contentious 126, 127 . However, many studies have used transgenic expression of chemokines or cytokines to drive TLT formation 125 , which indicates that the dissection of these pathways could benefit from a greater focus on more relevant infection-or autoimmunity-induced inflammation models.
It is of particular interest that TLTs develop many of the structural characteristics of secondary lymphoid organs (SLOs). These include high endothelial venules expressing peripheral node addressin, lymphatics expressing lymphatic vessel endothelial hyaluronan receptor 1, organized B and T cell zones, and stromal cells that express CC-chemokine ligand 21 (CCL21) and CXC-chemokine ligand 13 (CXCL13). TLT structures can be loosely arranged and have fewer of the elements that make up SLOs, or they can form large highly organized tissues that correspond to areas of considerable local inflammation and the expression of lymphotoxins and chemokines. Although little is known about the structure and function of stromal cells in TLTs, ER-TR7
+ fibroblasts are present that express CCL21, as well as CD35 + or CD21 + stromal cells expressing CXCL13 (reFs 124, 128) . It is unclear whether these stromal networks form conduits and provide traction for lymphocyte motility in these tissues, as they do in SLOs. Understanding how the stromal cell networks in TLTs can influence immune cell trafficking, survival and differentiation into pathogenic effector cells is highly important for determining ways to modulate these structures during inflammatory diseases and devise therapeutic interventions to benefit the patient. 
Stromal subsets in SLos
The non-haematopoietic cell types in the spleen and lymph nodes can be divided into at least seven subsets on the basis of their location, function and phenotype ( FRCs. Reticular networks have been observed in tissues such as lymph nodes for more than 100 years (cited in reF. 22) , although the cellular components of these networks only began to be characterized in the 1960s 13, 23, 24 . It was initially assumed that the role of FRCs in lymphoid organs was mainly structural, possibly to assist in the expansion and contraction of the lymph nodes during immune responses and to facilitate antigen or antibody transport. Subsequently, Anderson and Shaw 25 proposed that the transport of cytokines from the afferent lymph to HeVs involved conduits formed by FRCs. This was then directly shown in the lymph nodes 26 and spleen 27 , heralding a new appreciation of the functions of the lymphoid stroma.
The FRCs in the T cell zones of the spleen and lymph nodes surround the central arterioles and HeVs, respectively, forming a dense network filled with lymphocytes 25 . We now know from live imaging studies using twophoton laser scanning microscopy that lymphocytes in these regions are in constant dynamic motion and that they move along FRC strands that function as guidance paths for cell migration 28 . FRCs produce and surround the collagen-rich reticular fibres, forming an enclosed conduit structure that is separate and distinct from the parenchyma of the lymphoid tissue (FIG. 3) . Small molecules, such as chemokines and antigens, can enter the conduit network in lymph nodes from the lymph and are delivered rapidly to T cell zones and HeVs 26 . Molecules of high molecular mass cannot enter the conduit lumen and instead are trapped by SCS macrophages and accumulate in the cortical sinuses or continue around the SCS and drain through efferent lymphatic vessels. Such functional exclusion of large molecules and particles could restrict the types of signal delivered by the FRC conduits and prevent their exploitation by pathogens. In the spleen, FRCs in the T cell zones also collect blood-borne molecules in conduit structures 27 . Interestingly, molecular exclusion apparently differs in the spleen, as 70 kDa dextran enters the splenic conduits 27 but is excluded from lymph node conduits 26 . This raises the possibility that the system is tuned to allow delivery of distinct signals through the conduit networks in the T cell zones of different SLOs.
The reticular fibres in the T cell zones are rich in collagen, and the surrounding FRCs produce tissue transglutaminase and other molecules that are involved in the formation of these fibres (TABLe 1; see  Supplementary information S2 (table) ). FRCs, similar to many fibro blasts in different tissues, express an antigen recognized by the antibody eR-TR7 (reF. 29) and can be differentiated from other (non-endothelial) lymphoid stromal cells by their expression of podoplanin (also known as gp38) 30 . FRCs are also readily identified by their production of the chemokines CCL19 and CCL21 (reF. 31) , which are crucial for delineating the T cell zones and have important roles in promoting the migration of lymphocytes and DCs that express CC-chemokine receptor 7 (CCR7) 32 . FRCs in the T cell zones of humans and rodents express extra cellular matrix (eCM) components (such as the eR-TR7 antigen, fibrillin and the common basement membrane components laminin and fibronectin) and intracellular molecules that are found in some fibroblasts (such as desmin and α-smooth muscle actin). These products could be involved in the formation of FRC networks, the expansion and contraction of the cellular network and the presentation of molecules such as chemokines. FRCs also express integrin subunits and the adhesion ligands intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1). Nevertheless, so far no truly FRC-specific marker has been identified, and little is known about the expression of cytokines and membrane receptors, such as pattern recognition receptors, by these cells.
FDCs.
FDCs cluster in the centre of B cell follicles in the spleen, lymph nodes and other lymphoid tissues, including the peyer's patches. They form a dense network in which B cells search for antigen and receive differentiation signals after they are activated. FDCs express Fc receptors (such as CD16, CD23 and CD32), complement receptors (such as CD21 and CD35) and complement components (such as C4) (TABLe 1) . This facilitates the capture and presentation of unprocessed antigen, particularly in the form of immune complexes. FDCs also express high levels of VCAM1 and mucosal vascular addressin cell adhesion molecule 1 (MADCAM1), as well as molecules that are common to all subsets of stromal cells in the lymphoid tissues, such as desmin and laminin. Importantly, FDCs produce the chemokine CXC-chemokine ligand 13 (CXCL13), which attracts B cells expressing CXC-chemokine receptor 5 (CXCR5) into follicles in the steady state 33 . During an immune response, germinal centre reactions drive the formation of long-lived plasma cells and memory B cells, the immunoglobulin genes of which have undergone somatic hypermutation and class switch recombination. Interactions between B cells, FDCs and follicular T helper cells occur in the germinal centre in a highly dynamic manner 34, 35 . In the germinal centre 'light zone' , B cells interact with FDCs expressing CXCL13, whereas interactions with CXCL12-expressing stromal cells occur in the germinal centre 'dark zone' . It is unclear whether these 
CXCL12
+ cells are a subset of FDCs or whether they are a distinct type of stromal cell. Movement of B cells between the two germinal centre compartments seems to occur readily, although stromal chemokine signals might differentially retain B cells in different states of activation in the two compartments at different times 36 . Hence, the timing of B cell movement between light and dark zones (and therefore B cell activation and differentiation) might be controlled by stromal cells in the B cell follicle.
MRCs. Networks of non-haematopoietic cells form a layer underneath the SCS in lymph nodes, in the marginal zone of the spleen (particularly at the edges of B cell follicles) and also in MALT. These stromal cells have a phenotype that is distinct from that of stromal cells in the B and T cell zones (that is, of FDCs and FRCs, respectively). MRCs express many markers in common with other subsets of stromal cells, such as eR-TR7 antigen, desmin, laminin, VCAM1, MADCAM1 and a molecule recognized by the antibody 1BL-11 (reFs 10,37) (TABLe 1) . However, MRCs seem to uniquely express the tumour necrosis factor family member RANKL (receptor activator of NF-κB ligand; also known as TRANCe and TNFSF11) 10 .
These cells might be integral organizers of SLO structure during organogenesis 10 . It is interesting to note that many of the MRCs at the edges of the B cell follicles express CXCL13, which is similar to the centrally located FDCs 10, 38 . These MRCs also form a functional conduit network that can deliver antigens from the lymph node SCS to B cell follicles 39 . The stromal cells in the splenic marginal zone, together with the marginal zone metallo philic macrophages, might have roles in the delivery of antigen to the B cell follicles, which is similar to their role described in lymph nodes 39, 40 . So, MRCs might be a specialized subset of lymphoid stromal cells with important roles in the capture and delivery of antigens.
Splenic red pulp fibroblasts and lymph node medullary fibroblasts. The cords in the red pulp of the spleen have a crucial role in filtering the blood. They are composed of a highly compact network of fibroblasts and reticular fibres that contributes to immune defence through the production of cytokines, including interleukin-6 (IL-6) 41 . Macrophages in the red pulp cords also have numerous antimicrobial functions in addition to phagocytosing red blood cells and recycling iron, which might be supported by this stromal (TABLe 1) , which potentially assist in the localization of different cells in the red pulp 42 . For example, short-lived plasma cells, which express high levels of CXCR4 and the integrin lymphocyte functionassociated antigen 1 (LFA1), and low levels of CXCR5 and CCR7, localize in the splenic red pulp, where red pulp fibroblasts express ICAM1 (which binds LFA1) and CXCL12 (which binds CXCR4) 41, 43 . These molecules help to direct the movement of plasma cells into the red pulp, where they secrete large amounts of immuno globulins into the circulation. During acute stress from infections such as malaria or from the presence of endotoxins or IL-1, the splenic red pulp fibroblasts activate and fuse, forming so-called barrier cells 44, 45 , and this might alter or restrict blood flow and filtering during times of stress. Changes in fibroblast function in the marginal sinuses around the white pulp could also have a role in controlling cell entry to or exit from the spleen at certain times.
A dense network of fibroblasts and reticular fibres forms a framework in the medullary cords of lymph nodes, as well as a loose network in medullary sinuses 46, 47 . Many macrophages and plasma cells, as well as DCs, lympho cytes and mast cells, can be found in the lymph node medulla 46 ; it is therefore probable that lymph node medullary fibroblasts have specialized roles in the induction of immune responses. Indeed, because the expression of CXCL12 is mainly restricted to the medulla in lymph nodes 43 , it is possible that fibroblasts in this region might have similar roles to red pulp fibroblasts in directing plasma cell localization, but clearly much more remains to be learned about this stromal cell population.
Stromal cells and lymphocyte migration in SLos
A fundamental challenge faced by the immune system is the complexity of antigen-specific recognition and the need for individual cells to locate their cognate antigen in the vast network of lymphoid tissues. Cell entry into SLOs has been most extensively studied with respect to lymph node HeVs, as well as across inflamed endothelium in non-lymphoid tissues (reviewed in reFs 48, 49) . entry involves a series of molecular interactions between leukocytes and the specialized vascular endothelial cells. entry from the blood into the spleen occurs through the marginal sinuses in the marginal zone, which express MADCAM1, although the exact steps involved are unknown. Cells that enter lymph nodes from the tissues do so through the lymphatics and mainly consist of ApCs and activated T cells. entry into the lymphatics from the tissues requires CCR7 expression by the migrating cells 50, 51 , but it does not seem to require integrins; DCs lacking all integrin heterodimers migrate to lymph nodes, whereas Ccr7 -/-DCs do not 52 . Regardless of the route by which cells enter the SLOs, immediately after entry they come into direct contact with the stromal microenvironment.
T cell trafficking in SLOs. T cells come into immediate contact with the FRC network after crossing lymph node
HeVs or with the marginal zone and red pulp fibro blasts after entering the spleen. T cell movement in lymphoid tissues is remarkably dynamic, with cells moving at average speeds of 8-11 μM per minute 53, 54 . FRCs in the T cell zone produce high levels of CCL21, and to a lesser extent CCL19, which is found on the surface of the reticular network together with eCM components 31 . CCL21 binds to CCR7 and provides directional clues to T cells, as shown by the phenotype of plt/plt mice, the T cells of which do not localize in the white pulp of the spleen 7, 55 . Moreover, FRCs and CCL21 seem to delineate the boundary of the T cell zones, and T cells have been observed to turn around once they reach the B cell-T cell border 28 . This is most probably due to the lack of CCL21 expression in CXCL13-rich B cell follicles and the absence of the receptor for CXCL13, CXCR5, on naive T cells.
In both spleen and lymph nodes, naive T cells crawl along the surface of the FRC network and change direction apparently randomly at intersections in the FRC network while moving along the pathways that correspond to the processes and cell bodies of these stromal cells 7, 28 (FIG. 3) . The motility of T cells in lymph nodes is at least partially dependent on CCL21 (reFs 56-58).
Binding of ligands such as CCL21 to CCR7 on T cells in SLOs might result in the induction of continuous signalling to drive T cell motility 59 . The integrins LFA1 and very late antigen 4 (VLA4), however, do not seem to be required for T cell movement in SLOs. These integrins are not activated in the lymphoid environment and may require the strong shear forces that are present in blood vessels to become activated 60 . Studies suggest that other chemokines probably also have a role in T cell motility through Gαi-coupled receptor signalling, as blocking chemokine receptor signalling with pertussis toxin induced a greater decrease in T cell movement than removing only the CCR7-mediated signals. However in the absence of chemokine signals, T cells retain some motility, indicating that non-Gαi-dependent signals might also contribute to this process 57, 61 . Indeed, stromal cell-derived adhesion molecules, integrins and glycoproteins (such as VCAM1 and podoplanin) might provide traction for lymphocytes and/or modulate the way in which they migrate through the SLOs, and expression of sialic acid by stromal cells in the spleen is known to be important for lymphocyte trafficking into the white pulp 62 . Moreover, FRCs express MHC class I molecules and the inhibitory molecule programmed cell death ligand 1 (pDL1; also known as CD274) 63 , and might deliver signals to T cells moving along their surface, potentially influencing tolerance versus immune responses by tuning the responsiveness or activation state of the T cells.
Chemokines that are produced by lymphoid stromal cells (such as CCL21) provide strong retention signals to T cells that allow them to stay in SLOs for as long as 12 hours or more while they search for antigen 64 . To continue their body-wide surveillance, T cells must exit SLOs, and they do so in an S1p-dependent manner 65 . Specifically, S1p levels are considerably higher in the blood and lymph than in SLOs owing to the action of S1p lyase in SLOs 66 . T cells modulate their expression of S1p 1 as they traffic between tissues, expressing low levels when in the blood and lymph and upregulating receptor expression and response sensitivity in SLOs over time 67 . This cyclical pattern of receptor expression controls the ability of T cells to overcome CCL21-mediated retention signals in SLOs 68 and enter the lymphatics 17 ; this same process might also control cell movement out of the spleen 19 .
B cell trafficking in SLOs. When CXCR5 + B cells enter the spleen or lymph nodes they migrate into B cell follicles in response to CXCL13 produced by FDCs. As they exit the HeVs, B cells first crawl on the FRC network and make their way towards the B cell follicles 28 . Once there, B cells migrate at a speed of approximately 6 μM per minute 53 in close association with the dense networks of FDCs in the centre of the follicles (FIG. 3) . Given that stromal cells, possibly MRCs, in the periphery of the B cell follicles in both spleen and lymph nodes also express CXCL13, it is probable that B cells move in a similar manner along these cells. 19 , and plasma cells also use S1p signals to exit the spleen and migrate to the bone marrow 69 .
Additional functions of SLo stromal cells
Interactions with APCs. SLOs are ideally suited to capture antigen from around the body and contain numerous subsets of DCs and macrophages that are specialized in terms of both function and location. A key issue of interest is the relationship between these ApC populations and the stromal cell elements of SLOs. Resident and migratory subsets of CD11c + DCs are found in lymph nodes, whereas the spleen contains mostly resident DCs 70 . DCs accumulate near the HeVs in lymph nodes and in the marginal zone bridging channels in the spleen, thereby increasing the probability that B and T cells will encounter their cognate antigen on entering these SLOs 9, 71, 72 . In lymph nodes, resident DCs form a stable organized network, adhering to FRCs in the T cell zone 28 . CD8α + resident DCs in particular are tightly associated with the CCL21-rich FRC network in lymph nodes 28, 73 . The CD8α -subset of resident DCs is found in the splenic marginal zone, particularly at the bridging channels 74 , but it has not been reported whether the corresponding subset occupies a discrete region in lymph node T cell zones. This raises the intriguing question of whether the stromal cell components of SLOs have a role in the subregion-specific localization of distinct DC subsets, which in turn influences where specific types of immune activation events will occur. Such a possibility is supported by the finding that the two subsets of migratory DCs in lymph nodesLangerhans cells and interstitial DCs (dermal DCs from the skin) -are asymmetrically distributed in the lymph nodes, being found in deep T cell zones and in the region separating the B and T cell zones, respectively 75 . New studies are needed to determine whether the FRCs in these regions differ in their expression of adhesion or chemotactic molecules that might guide such distinct tissue distributions.
DCs migrating from the tissues must express CCR7 to readily enter lymphatics, and CCL19 and/or CCL21 expression is required for DCs to migrate to T cell zones in the spleen and lymph nodes 76, 77 . In the spleen, CD169 + marginal zone macrophages require CCL21 to localize to the marginal zone 78 . Migrating DCs might also use the stromal networks as a substrate for movement, similarly to lymphocytes. Local expression of the chemokines CCL19 and CCL21 by FRCs can promote immune responses by co-stimulating T cell activation 79 , increasing T cell interactions with ApCs 80 , promoting the maturation of DCs 81 , stimulating endocytosis and antigen presentation by DCs 82 and evoking the extension and probing of dendrites by DCs 83 . Activated DCs also produce chemokines such as CCL3 and CCL4 that assist in the recruitment of rare antigen-specific T cells through directed trafficking on FRCs 84 . Therefore, interactions between FRCs and DCs, as well as the chemokines that both cell types produce, assist in the priming of immune responses.
Stromal cells also contribute to ApC functionality in other ways. DCs that associate with FRCs in the T cell zones take up antigen transported in the conduits and present it to T cells 73, 85 . Macrophages can also be found in close association with stromal cells in SLOs. The CD169 + macrophages in the SCS of lymph nodes and the marginal zone of the spleen sit on a network of MRCs. These macrophages capture antigens and then transfer them to resident or arriving DCs or to B cells 11, 40, 86 , although so far there is no evidence that stromal cells contribute to the antigen presentation function of these macrophages in the same way that FRC conduits do for DCs.
Control of immune responses. pathogen infections result in marked changes to SLOs, many of which are driven by responses of the innate and adaptive immune systems.
In lymph nodes, the egress of cells is blocked for several days after infection 87 . Similarly, cell accumulation in the white pulp of the spleen increases soon after infection. This concerted change in the trafficking of cells through SLOs is due to the release of inflammatory mediators such as type I interferons, which transiently suppress cell egress 88 . Inflammation also induces an increase in arterial vessel diameter and increased CCL21 expression by HeVs, resulting in increased blood flow through the lymph nodes and enhanced cellular input 89, 90 . Increased expression of vascular endothelial growth factor (VeGF) results in the rapid proliferation of vascular endothelial cells, including cells of the HeVs, and growth of the blood vessels 91, 92 . In addition, the expansion of lymph node lymphatic sinuses mediated by VeGF-A could assist in the recruitment of cells such as ApCs from the tissues 93 . Although DCs and B cells are crucial for these processes 92, 93 , it was recently shown that CD45 -CD31 -podoplanin + lymph node stromal cells (that is, FRCs) are the main cell type expressing Vegf mRNA in lymph nodes 94 . Remodelling of the SLOs, particularly inflamed lymph nodes, which increase markedly in size 95 , indicates that expansion of the stromal cell network might also involve the proliferation of FRCs. This implicates could contribute to the immune suppression that is observed during several human infections, including measles and influenza. The lymphoid stroma might also shape immune responses in other ways. For example, it was recently found that stromal cells from mesenteric lymph nodes, but not peripheral lymph nodes, express the vitamin A metabolite retinoic acid 97 , and T cells primed in this stromal environment had a gut-homing phenotype (expression of α4β7 integrin and CCR9). Lymphoid stromal cells from mesenteric lymph nodes were also much better at inducing IgA responses than stromal cells from peripheral lymph nodes 98 . Together, these data indicate that stromal cells can direct the quality and type of immune response in SLOs. Moreover, antigen presentation by stromal cells can contribute to immune responses, for example, by increasing the T cell response after viral infection 99 . Conversely, during chronic infections in which antigen levels are high, this might overstimulate responding lymphocytes, resulting in immune exhaustion 100 . These studies show that, in combination with inhibitory ligands (such as pDL1) expressed by FRCs and other non-haematopoietic cells 63 , lymphoid stromal cells have a marked effect on the size and quality of immune responses. 
This proliferation of T cells occurs in the T cell zones of
SLOs and it is absent in lymphotoxin-α-deficient mice, which lack lymph nodes, organized B and T cell zones in the spleen, CCL21 and CXCL13, and have disorganized FRC and FDC networks 103 . These observations indicate that T cells compete for survival factors in SLOs and that the overall size of the lymphocyte pool might be controlled by competition for such signals. In vitro experiments with SLO stromal cells suggest that they can support the survival of resting T cells 104 . More recently, it was found that FRCs in the T cell zone might be a primary source of IL-7 and CCL19 in lymph nodes, and that together these factors are important for T cell homeostasis 105 . Interestingly, studies using mice expressing IL-7 together with a fluorescent reporter indicate that cells near the lymph node SCS might express high levels of IL-7 (reF. 106) , raising the possibility that MRCs also express IL-7 or have contaminated the putative FRC preparations that are claimed to produce this trophic cytokine. physical competition for these apparently limited resources and a dependence on migration through the SLOs to obtain them are probably part of a tightly regulated pathway that controls the T cell population size. B cells also require a survival factor, B cell activating factor (BAFF), for homeostasis, although they do not require IL-7 signals in mice 107 . FDCs express BAFF and can control B cell homeostasis by providing this signal to BAFF receptor-expressing B cells 108 . Finally, in vitro experiments indicate that T cells might be required for the proper formation of FRC networks 95 , which raises the intriguing possibility that crosstalk between immune cells and SLO stromal cells is important for the health and/or survival of both cell types.
Peripheral tolerance. Most T cells that express antigen receptors with a strong affinity for self antigens are deleted in the thymus. However, the deletion mechanism is incomplete, and it requires mechanisms of peripheral tolerance to prevent the activation of self-reactive T cells and autoimmunity. In addition to trans-suppression by regulatory T cells, the deletion of autoreactive cells in lymph nodes is thought to be important and to involve the cross-presentation of self antigens to T cells by DCs, which can take up antigen in the tissues or peripheral organs and migrate to draining lymph nodes 70 . DCs might not be the only cell type involved in such intranodal tolerance induction, however, as recent reports have found that a subset of stromal cells in the lymph nodes expresses the autoimmune regulator (AIRe) and a range of tissue-derived self antigens 109, 110 . It is not yet known whether these cells are a unique stromal cell subset or whether several different cell types have this property, as one study using transgenic mice expressing AIRe together with green fluorescent protein identified both bone marrow-derived and non-bone-marrow-derived AIRe-expressing cells in the periphery 109 . CD8 + T cells that interacted with the self antigen-expressing stromal cells were subsequently deleted 109, 110 , which indicates that this might be an important mechanism of peripheral tolerance. However, further experiments will be needed to determine whether interactions with DCs are also required to initiate or complete the tolerogenic process, and whether different cell types (DCs and stromal cells) are involved in tolerizing CD4 + and CD8 + T cells. Nevertheless, it is intriguing to consider the possibility that the very cells that migrating naive T cells must constantly contact as they move within lymph nodes can present tissue-specific antigens and potentially tolerize the T cells.
pathogen interactions with lymphoid stromal cells It is becoming increasingly apparent that lymphoid stromal cells, in particular FRCs, are targeted by several intracellular pathogens (TABLe 2) . Lymphocytic choriomeningitis virus (LCMV) clone 13 directly infects T cell zone FRCs in the spleen and lymph nodes 63 . Viral infection in the red pulp, marginal zone and B cell follicles indicates that LCMV clone 13 116, 117 . During acute and latent infection of mice with mouse cytomegalovirus, endothelial cells and stromal cells are the main target of infection in the spleen and bone marrow, which could contribute to latency and immune suppression [118] [119] [120] . Infection of mice with the malaria parasite Plasmodium yoelii results in marked changes to red pulp fibroblasts 45, 121 (red pulp stromal cells become highly metabolically active with expanded endoplasmic reticulum), which potentially have many roles in protection from malaria. Indeed, the fusing of red pulp fibroblasts and the formation of splenic barrier cells contribute to protection from malaria by restricting parasite access to much of the splenic cords. However, during lethal P. yoellii 17XL infection, large numbers of splenic red pulp stromal cells become infected with the parasite and contribute to disease, which might reflect a different tropism, infectivity or rate of replication by the 17XL strain. Finally, prion proteins have been found to be associated with stromal elements in the spleen and in granulomas 122 . So, various pathogens seem to use lymphoid stromal cells to spread and persist, which can have important consequences for SLO function and immunity. In addition, there have been rare reports of patients with aggressive tumours that result from FRC neoplasms in the spleen and lymph nodes 123 .
concluding remarks
The presence of non-haematopoietic elements in SLOs has been recognized by anatomists for more than a century. For most of this time, these cells were considered to have mainly a structural role, forming the skeleton of the SLO in which the haematopoietic components carried out their function. This view has given way over time to a more holistic concept, one in which the stromal cell components are actively engaged in functional interactions with the lymphoid and myeloid cells, providing survival signals, pathways for migration, channels for delivery of antigens and inflammatory stimuli, and chemokine cues that help to establish the B and T cell zones of SLOs. Stromal networks are a dynamic component of SLOs and consist of diverse cell types with distinct but overlapping functions. At least some stromal cells contribute to tolerance induction rather than the induction of active immune responses. Cells in the stroma are the targets of infectious agents, either as direct sites for replication or as substrates for functional changes that in turn affect adaptive immune responses. In short, the stromal cell components of the immune system are key players of host defence, but we know much less about their biology than about the haematopoietic cells that we typically consider to be the building blocks of host defence. If we are to better understand the immune system as a whole, a deeper understanding of stromal cell biology, from cellular heterogeneity and plasticity to molecular composition to intercellular communication mechanisms and more, is surely a crucial element in moving towards this goal. Such increased knowledge of the biology and function of stromal cells could provide avenues of therapeutic value for vaccine design or the treatment of autoimmune diseases and infections. 
